Not available
Quote | Verastem Inc. (NASDAQ:VSTM)
Last: | $2.94 |
---|---|
Change Percent: | -0.97% |
Open: | $3.13 |
Close: | $2.94 |
High: | $3.13 |
Low: | $2.935 |
Volume: | 552,198 |
Last Trade Date Time: | 06/25/2024 03:00:00 am |
News | Verastem Inc. (NASDAQ:VSTM)
2024-06-12 09:44:18 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 12, 2024 – USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovere...
2024-06-10 10:51:25 ET Summary Verastem's stock has dipped by about 70% following updated clinical data in low-grade serous ovarian cancer and pancreatic ductal adenocarcinoma. Reasons for the dip include a lower than previously reported ORR in LGSOC, plans for NDA submission for ...
Message Board Posts | Verastem Inc. (NASDAQ:VSTM)
Subject | By | Source | When |
---|---|---|---|
Happy I hit and run. I would consider | Harbor6460 | investorshub | 06/09/2023 4:06:50 PM |
$VSTM The gaining | Tartiaboy | investorshub | 06/08/2023 9:42:19 PM |
$VSTM news all the way baby | Tartiaboy | investorshub | 06/04/2023 12:16:39 PM |
They definite are diluting. They need money. | Harbor6460 | investorshub | 05/29/2023 2:44:48 PM |
highest volume in history -insert dd- | The Night Stalker | investorshub | 05/29/2023 5:53:28 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-12 09:44:18 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 12, 2024 – USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovere...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 428.5% to $0.983 on volume of 924,758,481 shares Greenwave Technology Solutions Inc. (GWAV) fell 4.2% to $0.0849 on volume of 393,457,542 shares Netcapital Inc. (NCPL) rose 10.1% to $0.1925 on volum...
2024-05-24 11:30:00 ET Verastem Inc (NASDAQ: VSTM) opened nearly 70% down this morning even though the pharmaceutical firm reported positive interim data for its combination therapy as a treatment of pancreatic cancer. Here’s what is hitting $VSTM today The oncology compa...